• 30-Nov-2017

    CommSec Executive Series interviews CEO & Managing Director, Dr James Garner about the company's recent name change from Novogen to Kazia Therapeutics and progress of its ovarian cancer and brain cancer drug trials
  • 04-Jul-2017

    CommSec Executive Series interviews CEO Dr James Garner on benefits of new business model for patients
  • 19-May-2017

    ASX CEO Session interview with FNN
  • 1-May-2017

    Dr James Garner, CEO, speaks to Canary Networks investment forum
  • 19-Apr-2017

    Briefing on ATM program by our CEO, Dr James Garner to the Hon Paul Fletcher MP, Minister for Bradfield
  • 2-Nov-2016

    Dr James Garner discusses in-licencing of GDC-0084 with FNN
  • 31-Oct-2016

    Sky News Interview – In-licensing of GDC-0084